SMSPHARMA.BOSMSPHARMA.BOBSE
Loading
Cost of Revenue Over TimeStrong
Percentile Rank100
3Y CAGR+19.5%
5Y CAGR+12.1%
Studio
Year-over-Year Change

Direct costs attributable to producing goods sold

3Y CAGR
+19.5%/yr
vs +4.7%/yr prior
5Y CAGR
+12.1%/yr
Recent acceleration
Acceleration
+14.9pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.8x
Solid growth
Streak
4 yr
Consecutive growthStrong
PeriodValueYoY Change
TTM$6.71B+5.3%
2025$6.38B+28.0%
2024$4.98B+26.8%
2023$3.93B+17.9%
2022$3.34B-12.1%
2021$3.79B+35.5%
2020$2.80B-14.5%
2019$3.28B+1.0%
2018$3.24B-22.0%
2017$4.16B-